Found 30 hits for UniProtKB: Q08462 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Adenylate cyclase
(Homo sapiens (Human)) | BDBM50144001
 (3-{4-[1-(2',4'-Dichloro-biphenyl-4-ylcarbamoyl)-he...)Show SMILES CCCCCCC(Oc1ccc(cc1)C(=O)NCCC(O)=O)C(=O)Nc1ccc(cc1)-c1ccc(Cl)cc1Cl Show InChI InChI=1S/C30H32Cl2N2O5/c1-2-3-4-5-6-27(39-24-14-9-21(10-15-24)29(37)33-18-17-28(35)36)30(38)34-23-12-7-20(8-13-23)25-16-11-22(31)19-26(25)32/h7-16,19,27H,2-6,17-18H2,1H3,(H,33,37)(H,34,38)(H,35,36) | PDB
Reactome pathway
UniProtKB/SwissProt UniProtKB/TrEMBL
antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| 14 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Abbott Laboratories
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against glucagon induced human adenylate cyclase |
Bioorg Med Chem Lett 14: 2047-50 (2004)
Article DOI: 10.1016/j.bmcl.2004.02.056 BindingDB Entry DOI: 10.7270/Q2XS5TTH |
More data for this Ligand-Target Pair | |
Adenylate cyclase
(Homo sapiens (Human)) | BDBM50144020
 (3-{4-[1-(4-Benzofuran-2-yl-phenylcarbamoyl)-heptyl...)Show SMILES CCCCCCC(Oc1ccc(cc1)C(=O)NCCC(O)=O)C(=O)Nc1ccc(cc1)-c1cc2ccccc2o1 Show InChI InChI=1S/C32H34N2O6/c1-2-3-4-5-10-28(39-26-17-13-23(14-18-26)31(37)33-20-19-30(35)36)32(38)34-25-15-11-22(12-16-25)29-21-24-8-6-7-9-27(24)40-29/h6-9,11-18,21,28H,2-5,10,19-20H2,1H3,(H,33,37)(H,34,38)(H,35,36) | PDB
Reactome pathway
UniProtKB/SwissProt UniProtKB/TrEMBL
antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| 17 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Abbott Laboratories
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against glucagon induced human adenylate cyclase |
Bioorg Med Chem Lett 14: 2047-50 (2004)
Article DOI: 10.1016/j.bmcl.2004.02.056 BindingDB Entry DOI: 10.7270/Q2XS5TTH |
More data for this Ligand-Target Pair | |
Adenylate cyclase
(Homo sapiens (Human)) | BDBM50144015
 (3-{4-[2-(4-Benzofuran-2-yl-phenylcarbamoyl)-octyl]...)Show SMILES CCCCCCC(Cc1ccc(cc1)C(=O)NCCC(O)=O)C(=O)Nc1ccc(cc1)-c1cc2ccccc2o1 Show InChI InChI=1S/C33H36N2O5/c1-2-3-4-5-9-27(21-23-11-13-25(14-12-23)32(38)34-20-19-31(36)37)33(39)35-28-17-15-24(16-18-28)30-22-26-8-6-7-10-29(26)40-30/h6-8,10-18,22,27H,2-5,9,19-21H2,1H3,(H,34,38)(H,35,39)(H,36,37) | PDB
Reactome pathway
UniProtKB/SwissProt UniProtKB/TrEMBL
antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 20 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Abbott Laboratories
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against glucagon induced human adenylate cyclase |
Bioorg Med Chem Lett 14: 2047-50 (2004)
Article DOI: 10.1016/j.bmcl.2004.02.056 BindingDB Entry DOI: 10.7270/Q2XS5TTH |
More data for this Ligand-Target Pair | |
Adenylate cyclase
(Homo sapiens (Human)) | BDBM50144008
 (3-{4-[2-(4-Benzofuran-2-yl-phenylcarbamoyl)-2-(4-t...)Show SMILES CC(C)(C)c1ccc(cc1)C(Cc1ccc(cc1)C(=O)NCCC(O)=O)C(=O)Nc1ccc(cc1)-c1cc2ccccc2o1 Show InChI InChI=1S/C37H36N2O5/c1-37(2,3)29-16-12-25(13-17-29)31(22-24-8-10-27(11-9-24)35(42)38-21-20-34(40)41)36(43)39-30-18-14-26(15-19-30)33-23-28-6-4-5-7-32(28)44-33/h4-19,23,31H,20-22H2,1-3H3,(H,38,42)(H,39,43)(H,40,41) | PDB
Reactome pathway
UniProtKB/SwissProt UniProtKB/TrEMBL
antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 29 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Abbott Laboratories
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against glucagon induced human adenylate cyclase |
Bioorg Med Chem Lett 14: 2047-50 (2004)
Article DOI: 10.1016/j.bmcl.2004.02.056 BindingDB Entry DOI: 10.7270/Q2XS5TTH |
More data for this Ligand-Target Pair | |
Adenylate cyclase
(Homo sapiens (Human)) | BDBM50144002
 (3-{4-[2-(4-tert-Butyl-phenyl)-2-(2',4'-dichloro-bi...)Show SMILES CC(C)(C)c1ccc(cc1)C(Cc1ccc(cc1)C(=O)NCCC(O)=O)C(=O)Nc1ccc(cc1)-c1ccc(Cl)cc1Cl Show InChI InChI=1S/C35H34Cl2N2O4/c1-35(2,3)26-12-8-24(9-13-26)30(20-22-4-6-25(7-5-22)33(42)38-19-18-32(40)41)34(43)39-28-15-10-23(11-16-28)29-17-14-27(36)21-31(29)37/h4-17,21,30H,18-20H2,1-3H3,(H,38,42)(H,39,43)(H,40,41) | PDB
Reactome pathway
UniProtKB/SwissProt UniProtKB/TrEMBL
antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 33 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Abbott Laboratories
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against glucagon induced human adenylate cyclase |
Bioorg Med Chem Lett 14: 2047-50 (2004)
Article DOI: 10.1016/j.bmcl.2004.02.056 BindingDB Entry DOI: 10.7270/Q2XS5TTH |
More data for this Ligand-Target Pair | |
Adenylate cyclase
(Homo sapiens (Human)) | BDBM50144008
 (3-{4-[2-(4-Benzofuran-2-yl-phenylcarbamoyl)-2-(4-t...)Show SMILES CC(C)(C)c1ccc(cc1)C(Cc1ccc(cc1)C(=O)NCCC(O)=O)C(=O)Nc1ccc(cc1)-c1cc2ccccc2o1 Show InChI InChI=1S/C37H36N2O5/c1-37(2,3)29-16-12-25(13-17-29)31(22-24-8-10-27(11-9-24)35(42)38-21-20-34(40)41)36(43)39-30-18-14-26(15-19-30)33-23-28-6-4-5-7-32(28)44-33/h4-19,23,31H,20-22H2,1-3H3,(H,38,42)(H,39,43)(H,40,41) | PDB
Reactome pathway
UniProtKB/SwissProt UniProtKB/TrEMBL
antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 69 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Abbott Laboratories
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against glucagon induced monkey adenylate cyclase |
Bioorg Med Chem Lett 14: 2047-50 (2004)
Article DOI: 10.1016/j.bmcl.2004.02.056 BindingDB Entry DOI: 10.7270/Q2XS5TTH |
More data for this Ligand-Target Pair | |
Adenylate cyclase
(Homo sapiens (Human)) | BDBM50144003
 (3-{4-[2-(4-tert-Butyl-phenyl)-2-(4-trifluoromethox...)Show SMILES CC(C)(C)c1ccc(cc1)C(Cc1ccc(cc1)C(=O)NCCC(O)=O)C(=O)Nc1ccc(OC(F)(F)F)cc1 Show InChI InChI=1S/C30H31F3N2O5/c1-29(2,3)22-10-8-20(9-11-22)25(28(39)35-23-12-14-24(15-13-23)40-30(31,32)33)18-19-4-6-21(7-5-19)27(38)34-17-16-26(36)37/h4-15,25H,16-18H2,1-3H3,(H,34,38)(H,35,39)(H,36,37) | PDB
Reactome pathway
UniProtKB/SwissProt UniProtKB/TrEMBL
antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| 110 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Abbott Laboratories
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against glucagon induced human adenylate cyclase |
Bioorg Med Chem Lett 14: 2047-50 (2004)
Article DOI: 10.1016/j.bmcl.2004.02.056 BindingDB Entry DOI: 10.7270/Q2XS5TTH |
More data for this Ligand-Target Pair | |
Adenylate cyclase
(Homo sapiens (Human)) | BDBM50144016
 (3-{4-[(Biphenyl-4-ylcarbamoyl)-(4-tert-butyl-pheny...)Show SMILES CC(C)(C)c1ccc(cc1)C(Oc1ccc(cc1)C(=O)NCCC(O)=O)C(=O)Nc1ccc(cc1)-c1ccccc1 Show InChI InChI=1S/C34H34N2O5/c1-34(2,3)27-15-9-25(10-16-27)31(41-29-19-13-26(14-20-29)32(39)35-22-21-30(37)38)33(40)36-28-17-11-24(12-18-28)23-7-5-4-6-8-23/h4-20,31H,21-22H2,1-3H3,(H,35,39)(H,36,40)(H,37,38) | PDB
Reactome pathway
UniProtKB/SwissProt UniProtKB/TrEMBL
antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 144 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Abbott Laboratories
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against glucagon induced human adenylate cyclase |
Bioorg Med Chem Lett 14: 2047-50 (2004)
Article DOI: 10.1016/j.bmcl.2004.02.056 BindingDB Entry DOI: 10.7270/Q2XS5TTH |
More data for this Ligand-Target Pair | |
Adenylate cyclase
(Homo sapiens (Human)) | BDBM50144009
 (3-{4-[1-(4-tert-Butyl-cyclohexyl)-3-(4-trifluorome...)Show SMILES CC(C)(C)[C@H]1CC[C@@H](CC1)N(Cc1ccc(cc1)C(=O)NCCC(O)=O)C(=O)Nc1ccc(OC(F)(F)F)cc1 Show InChI InChI=1S/C29H36F3N3O5/c1-28(2,3)21-8-12-23(13-9-21)35(27(39)34-22-10-14-24(15-11-22)40-29(30,31)32)18-19-4-6-20(7-5-19)26(38)33-17-16-25(36)37/h4-7,10-11,14-15,21,23H,8-9,12-13,16-18H2,1-3H3,(H,33,38)(H,34,39)(H,36,37)/t21-,23- | PDB
Reactome pathway
UniProtKB/SwissProt UniProtKB/TrEMBL
antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar
| Purchase
CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| 254 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Abbott Laboratories
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against glucagon induced human adenylate cyclase |
Bioorg Med Chem Lett 14: 2047-50 (2004)
Article DOI: 10.1016/j.bmcl.2004.02.056 BindingDB Entry DOI: 10.7270/Q2XS5TTH |
More data for this Ligand-Target Pair | |
Adenylate cyclase
(Homo sapiens (Human)) | BDBM50144004
 (3-{4-[2-(Biphenyl-4-ylcarbamoyl)-2-(4-tert-butyl-p...)Show SMILES CC(C)(C)c1ccc(cc1)C(Cc1ccc(cc1)C(=O)NCCC(O)=O)C(=O)Nc1ccc(cc1)-c1ccccc1 Show InChI InChI=1S/C35H36N2O4/c1-35(2,3)29-17-13-27(14-18-29)31(23-24-9-11-28(12-10-24)33(40)36-22-21-32(38)39)34(41)37-30-19-15-26(16-20-30)25-7-5-4-6-8-25/h4-20,31H,21-23H2,1-3H3,(H,36,40)(H,37,41)(H,38,39) | PDB
Reactome pathway
UniProtKB/SwissProt UniProtKB/TrEMBL
antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Abbott Laboratories
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against glucagon induced human adenylate cyclase |
Bioorg Med Chem Lett 14: 2047-50 (2004)
Article DOI: 10.1016/j.bmcl.2004.02.056 BindingDB Entry DOI: 10.7270/Q2XS5TTH |
More data for this Ligand-Target Pair | |
Adenylate cyclase
(Homo sapiens (Human)) | BDBM50144012
 (4-[(Biphenyl-4-ylcarbamoyl)-(4-tert-butyl-phenyl)-...)Show SMILES CC(C)(C)c1ccc(cc1)C(Oc1ccc(cc1)C(=O)Nc1nnn[nH]1)C(=O)Nc1ccc(cc1)-c1ccccc1 Show InChI InChI=1S/C32H30N6O3/c1-32(2,3)25-15-9-23(10-16-25)28(30(40)33-26-17-11-22(12-18-26)21-7-5-4-6-8-21)41-27-19-13-24(14-20-27)29(39)34-31-35-37-38-36-31/h4-20,28H,1-3H3,(H,33,40)(H2,34,35,36,37,38,39) | PDB
Reactome pathway
UniProtKB/SwissProt UniProtKB/TrEMBL
antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| 317 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Abbott Laboratories
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against glucagon induced human adenylate cyclase |
Bioorg Med Chem Lett 14: 2047-50 (2004)
Article DOI: 10.1016/j.bmcl.2004.02.056 BindingDB Entry DOI: 10.7270/Q2XS5TTH |
More data for this Ligand-Target Pair | |
Adenylate cyclase
(Homo sapiens (Human)) | BDBM50144006
 (3-{4-[2-(4-tert-Butyl-phenyl)-2-(quinolin-3-ylcarb...)Show SMILES CC(C)(C)c1ccc(cc1)C(Cc1ccc(cc1)C(=O)NCCC(O)=O)C(=O)Nc1cnc2ccccc2c1 Show InChI InChI=1S/C32H33N3O4/c1-32(2,3)25-14-12-22(13-15-25)27(31(39)35-26-19-24-6-4-5-7-28(24)34-20-26)18-21-8-10-23(11-9-21)30(38)33-17-16-29(36)37/h4-15,19-20,27H,16-18H2,1-3H3,(H,33,38)(H,35,39)(H,36,37) | PDB
Reactome pathway
UniProtKB/SwissProt UniProtKB/TrEMBL
antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar
| CHEMBL PC cid PC sid UniChem
| Article PubMed
| 610 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Abbott Laboratories
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against glucagon induced human adenylate cyclase |
Bioorg Med Chem Lett 14: 2047-50 (2004)
Article DOI: 10.1016/j.bmcl.2004.02.056 BindingDB Entry DOI: 10.7270/Q2XS5TTH |
More data for this Ligand-Target Pair | |
Adenylate cyclase
(Homo sapiens (Human)) | BDBM50144005
 (3-{4-[2-(4-tert-Butyl-phenyl)-2-(4-hydroxymethyl-p...)Show SMILES CC(C)(C)c1ccc(cc1)C(Cc1ccc(cc1)C(=O)NCCC(O)=O)C(=O)Nc1ccc(CO)cc1 Show InChI InChI=1S/C30H34N2O5/c1-30(2,3)24-12-10-22(11-13-24)26(29(37)32-25-14-6-21(19-33)7-15-25)18-20-4-8-23(9-5-20)28(36)31-17-16-27(34)35/h4-15,26,33H,16-19H2,1-3H3,(H,31,36)(H,32,37)(H,34,35) | PDB
Reactome pathway
UniProtKB/SwissProt UniProtKB/TrEMBL
antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| 1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Abbott Laboratories
Curated by ChEMBL
| Assay Description In vitro inhibitory activity against glucagon induced human adenylate cyclase |
Bioorg Med Chem Lett 14: 2047-50 (2004)
Article DOI: 10.1016/j.bmcl.2004.02.056 BindingDB Entry DOI: 10.7270/Q2XS5TTH |
More data for this Ligand-Target Pair | |
Adenylate cyclase type 2
(Homo sapiens (Human)) | BDBM50551432
 (CHEMBL4758446)Show SMILES Cc1ccc(cc1)[C@H]1OC2([C@@H]3[C@H]1C(=O)N(C3=O)c1ccccc1Cl)C(=O)c1cccc(F)c1C2=O Show InChI InChI=1S/C27H17ClFNO5/c1-13-9-11-14(12-10-13)22-20-21(26(34)30(25(20)33)18-8-3-2-6-16(18)28)27(35-22)23(31)15-5-4-7-17(29)19(15)24(27)32/h2-12,20-22H,1H3/t20-,21-,22-,27?/m1/s1 | PDB
Reactome pathway
UniProtKB/SwissProt
antibodypedia GoogleScholar
| PC cid PC sid UniChem
| PubMed
| n/a | n/a | n/a | n/a | 345 | n/a | n/a | n/a | n/a |
Chinese Academy of Sciences
Curated by ChEMBL
| Assay Description Agonist activity at recombinant human AC2 expressed in HEK293 cells assessed as increase in cAMP level measured after 30 mins by LANCE Ultra cAMP Det... |
Eur J Med Chem 191: (2020)
|
More data for this Ligand-Target Pair | |
Adenylate cyclase type 2
(Homo sapiens (Human)) | BDBM50551438
 (CHEMBL4750740)Show SMILES Cc1ccc(cc1)[C@H]1OC2([C@@H]3[C@H]1C(=O)N(C3=O)c1ccccc1Cl)C(=O)c1ccccc1C2=O Show InChI InChI=1S/C27H18ClNO5/c1-14-10-12-15(13-11-14)22-20-21(26(33)29(25(20)32)19-9-5-4-8-18(19)28)27(34-22)23(30)16-6-2-3-7-17(16)24(27)31/h2-13,20-22H,1H3/t20-,21-,22-/m1/s1 | PDB
Reactome pathway
UniProtKB/SwissProt
antibodypedia GoogleScholar
| PC cid PC sid UniChem
| PubMed
| n/a | n/a | n/a | n/a | 170 | n/a | n/a | n/a | n/a |
Chinese Academy of Sciences
Curated by ChEMBL
| Assay Description Agonist activity at recombinant human AC2 expressed in HEK293 cells assessed as increase in cAMP level measured after 30 mins by LANCE Ultra cAMP Det... |
Eur J Med Chem 191: (2020)
|
More data for this Ligand-Target Pair | |
Adenylate cyclase type 2
(Homo sapiens (Human)) | BDBM50551441
 (CHEMBL4745593)Show SMILES Cc1ccc(cc1)[C@H]1OC2([C@@H]3[C@H]1C(=O)N(C3=O)c1ccc(C)c(Cl)c1)C(=O)c1ccccc1C2=O Show InChI InChI=1S/C28H20ClNO5/c1-14-7-10-16(11-8-14)23-21-22(27(34)30(26(21)33)17-12-9-15(2)20(29)13-17)28(35-23)24(31)18-5-3-4-6-19(18)25(28)32/h3-13,21-23H,1-2H3/t21-,22-,23-/m1/s1 | PDB
Reactome pathway
UniProtKB/SwissProt
antibodypedia GoogleScholar
| PC cid PC sid UniChem
| PubMed
| n/a | n/a | n/a | n/a | 750 | n/a | n/a | n/a | n/a |
Chinese Academy of Sciences
Curated by ChEMBL
| Assay Description Agonist activity at recombinant human AC2 expressed in HEK293 cells assessed as increase in cAMP level measured after 30 mins by LANCE Ultra cAMP Det... |
Eur J Med Chem 191: (2020)
|
More data for this Ligand-Target Pair | |
Adenylate cyclase type 2
(Homo sapiens (Human)) | BDBM50551431
 (CHEMBL4762531)Show SMILES Cc1ccc(cc1)[C@H]1OC2([C@@H]3[C@H]1C(=O)N(C3=O)c1ccccc1Cl)C(=O)c1cccc(Cl)c1C2=O Show InChI InChI=1S/C27H17Cl2NO5/c1-13-9-11-14(12-10-13)22-20-21(26(34)30(25(20)33)18-8-3-2-6-16(18)28)27(35-22)23(31)15-5-4-7-17(29)19(15)24(27)32/h2-12,20-22H,1H3/t20-,21-,22-,27?/m1/s1 | PDB
Reactome pathway
UniProtKB/SwissProt
antibodypedia GoogleScholar
| PC cid PC sid UniChem
| PubMed
| n/a | n/a | n/a | n/a | 301 | n/a | n/a | n/a | n/a |
Chinese Academy of Sciences
Curated by ChEMBL
| Assay Description Agonist activity at recombinant human AC2 expressed in HEK293 cells assessed as increase in cAMP level measured after 30 mins by LANCE Ultra cAMP Det... |
Eur J Med Chem 191: (2020)
|
More data for this Ligand-Target Pair | |
Adenylate cyclase type 2
(Homo sapiens (Human)) | BDBM50551428
 (CHEMBL4744718)Show SMILES Cc1ccc(cc1)[C@H]1OC2([C@@H]3[C@H]1C(=O)N(C3=O)c1ccccc1Cl)C(=O)c1ccc(F)cc1C2=O Show InChI InChI=1S/C27H17ClFNO5/c1-13-6-8-14(9-7-13)22-20-21(26(34)30(25(20)33)19-5-3-2-4-18(19)28)27(35-22)23(31)16-11-10-15(29)12-17(16)24(27)32/h2-12,20-22H,1H3/t20-,21-,22-,27?/m1/s1 | PDB
Reactome pathway
UniProtKB/SwissProt
antibodypedia GoogleScholar
| PC cid PC sid UniChem
| PubMed
| n/a | n/a | n/a | n/a | 692 | n/a | n/a | n/a | n/a |
Chinese Academy of Sciences
Curated by ChEMBL
| Assay Description Agonist activity at recombinant human AC2 expressed in HEK293 cells assessed as increase in cAMP level measured after 30 mins by LANCE Ultra cAMP Det... |
Eur J Med Chem 191: (2020)
|
More data for this Ligand-Target Pair | |
Adenylate cyclase type 2
(Homo sapiens (Human)) | BDBM50551427
 (CHEMBL4777571)Show SMILES Cc1ccc(cc1)[C@H]1OC2([C@@H]3[C@H]1C(=O)N(C3=O)c1ccccc1Cl)C(=O)c1ccc(Cl)cc1C2=O Show InChI InChI=1S/C27H17Cl2NO5/c1-13-6-8-14(9-7-13)22-20-21(26(34)30(25(20)33)19-5-3-2-4-18(19)29)27(35-22)23(31)16-11-10-15(28)12-17(16)24(27)32/h2-12,20-22H,1H3/t20-,21-,22-,27?/m1/s1 | PDB
Reactome pathway
UniProtKB/SwissProt
antibodypedia GoogleScholar
| PC cid PC sid UniChem
| PubMed
| n/a | n/a | n/a | n/a | 236 | n/a | n/a | n/a | n/a |
Chinese Academy of Sciences
Curated by ChEMBL
| Assay Description Agonist activity at recombinant human AC2 expressed in HEK293 cells assessed as increase in cAMP level measured after 30 mins by LANCE Ultra cAMP Det... |
Eur J Med Chem 191: (2020)
|
More data for this Ligand-Target Pair | |
Adenylate cyclase type 2
(Homo sapiens (Human)) | BDBM50551426
 (CHEMBL4751732)Show SMILES Cc1ccc(cc1)[C@H]1OC2([C@@H]3[C@H]1C(=O)N(C3=O)c1ccccc1Cl)C(=O)c1ccc(Br)cc1C2=O Show InChI InChI=1S/C27H17BrClNO5/c1-13-6-8-14(9-7-13)22-20-21(26(34)30(25(20)33)19-5-3-2-4-18(19)29)27(35-22)23(31)16-11-10-15(28)12-17(16)24(27)32/h2-12,20-22H,1H3/t20-,21-,22-,27?/m1/s1 | PDB
Reactome pathway
UniProtKB/SwissProt
antibodypedia GoogleScholar
| PC cid PC sid UniChem
| PubMed
| n/a | n/a | n/a | n/a | 90 | n/a | n/a | n/a | n/a |
Chinese Academy of Sciences
Curated by ChEMBL
| Assay Description Agonist activity at recombinant human AC2 expressed in HEK293 cells assessed as increase in cAMP level measured after 30 mins by LANCE Ultra cAMP Det... |
Eur J Med Chem 191: (2020)
|
More data for this Ligand-Target Pair | |
Adenylate cyclase type 2
(Homo sapiens (Human)) | BDBM50551425
 (CHEMBL4761309)Show SMILES Cc1ccc(cc1)[C@H]1OC2([C@@H]3[C@H]1C(=O)N(C3=O)c1ccccc1Cl)C(=O)c1ccc(C)cc1C2=O Show InChI InChI=1S/C28H20ClNO5/c1-14-7-10-16(11-8-14)23-21-22(27(34)30(26(21)33)20-6-4-3-5-19(20)29)28(35-23)24(31)17-12-9-15(2)13-18(17)25(28)32/h3-13,21-23H,1-2H3/t21-,22-,23-,28?/m1/s1 | PDB
Reactome pathway
UniProtKB/SwissProt
antibodypedia GoogleScholar
| PC cid PC sid UniChem
| PubMed
| n/a | n/a | n/a | n/a | 300 | n/a | n/a | n/a | n/a |
Chinese Academy of Sciences
Curated by ChEMBL
| Assay Description Agonist activity at recombinant human AC2 expressed in HEK293 cells assessed as increase in cAMP level measured after 30 mins by LANCE Ultra cAMP Det... |
Eur J Med Chem 191: (2020)
|
More data for this Ligand-Target Pair | |
Adenylate cyclase type 2
(Homo sapiens (Human)) | BDBM50551415
 (CHEMBL4744648)Show SMILES Cc1cc(C)cc(c1)N1C(=O)[C@H]2[C@H](OC3([C@H]2C1=O)C(=O)c1ccccc1C3=O)c1ccc(Cl)cc1 Show InChI InChI=1S/C28H20ClNO5/c1-14-11-15(2)13-18(12-14)30-26(33)21-22(27(30)34)28(35-23(21)16-7-9-17(29)10-8-16)24(31)19-5-3-4-6-20(19)25(28)32/h3-13,21-23H,1-2H3/t21-,22-,23-/m1/s1 | PDB
Reactome pathway
UniProtKB/SwissProt
antibodypedia GoogleScholar
| PC cid PC sid UniChem
| PubMed
| n/a | n/a | n/a | n/a | 310 | n/a | n/a | n/a | n/a |
Chinese Academy of Sciences
Curated by ChEMBL
| Assay Description Agonist activity at recombinant human AC2 expressed in HEK293 cells assessed as increase in cAMP level measured after 30 mins by LANCE Ultra cAMP Det... |
Eur J Med Chem 191: (2020)
|
More data for this Ligand-Target Pair | |
Adenylate cyclase type 2
(Homo sapiens (Human)) | BDBM50551414
 (CHEMBL4779970)Show SMILES Fc1ccc(cc1)N1C(=O)[C@H]2[C@H](OC3([C@H]2C1=O)C(=O)c1ccccc1C3=O)c1ccc(Cl)cc1 Show InChI InChI=1S/C26H15ClFNO5/c27-14-7-5-13(6-8-14)21-19-20(25(33)29(24(19)32)16-11-9-15(28)10-12-16)26(34-21)22(30)17-3-1-2-4-18(17)23(26)31/h1-12,19-21H/t19-,20-,21-/m1/s1 | PDB
Reactome pathway
UniProtKB/SwissProt
antibodypedia GoogleScholar
| PC cid PC sid UniChem
| PubMed
| n/a | n/a | n/a | n/a | 530 | n/a | n/a | n/a | n/a |
Chinese Academy of Sciences
Curated by ChEMBL
| Assay Description Agonist activity at recombinant human AC2 expressed in HEK293 cells assessed as increase in cAMP level measured after 30 mins by LANCE Ultra cAMP Det... |
Eur J Med Chem 191: (2020)
|
More data for this Ligand-Target Pair | |
Adenylate cyclase type 2
(Homo sapiens (Human)) | BDBM50551412
 (CHEMBL4764988)Show SMILES CCc1ccc(cc1)N1C(=O)[C@H]2[C@H](OC3([C@H]2C1=O)C(=O)c1ccccc1C3=O)c1ccc(Cl)cc1 Show InChI InChI=1S/C28H20ClNO5/c1-2-15-7-13-18(14-8-15)30-26(33)21-22(27(30)34)28(35-23(21)16-9-11-17(29)12-10-16)24(31)19-5-3-4-6-20(19)25(28)32/h3-14,21-23H,2H2,1H3/t21-,22-,23-/m1/s1 | PDB
Reactome pathway
UniProtKB/SwissProt
antibodypedia GoogleScholar
| PC cid PC sid UniChem
| PubMed
| n/a | n/a | n/a | n/a | 430 | n/a | n/a | n/a | n/a |
Chinese Academy of Sciences
Curated by ChEMBL
| Assay Description Agonist activity at recombinant human AC2 expressed in HEK293 cells assessed as increase in cAMP level measured after 30 mins by LANCE Ultra cAMP Det... |
Eur J Med Chem 191: (2020)
|
More data for this Ligand-Target Pair | |
Adenylate cyclase type 2
(Homo sapiens (Human)) | BDBM50551409
 (CHEMBL4789237)Show SMILES CCc1ccc(cc1)[C@H]1OC2([C@@H]3[C@H]1C(=O)N(C3=O)c1ccc(C)cc1)C(=O)c1ccccc1C2=O Show InChI InChI=1S/C29H23NO5/c1-3-17-10-12-18(13-11-17)24-22-23(28(34)30(27(22)33)19-14-8-16(2)9-15-19)29(35-24)25(31)20-6-4-5-7-21(20)26(29)32/h4-15,22-24H,3H2,1-2H3/t22-,23-,24-/m1/s1 | PDB
Reactome pathway
UniProtKB/SwissProt
antibodypedia GoogleScholar
| PC cid PC sid UniChem
| PubMed
| n/a | n/a | n/a | n/a | 670 | n/a | n/a | n/a | n/a |
Chinese Academy of Sciences
Curated by ChEMBL
| Assay Description Agonist activity at recombinant human AC2 expressed in HEK293 cells assessed as increase in cAMP level measured after 30 mins by LANCE Ultra cAMP Det... |
Eur J Med Chem 191: (2020)
|
More data for this Ligand-Target Pair | |
Adenylate cyclase type 2
(Homo sapiens (Human)) | BDBM50551407
 (CHEMBL4786932)Show SMILES Cc1ccc(cc1)[C@H]1OC2([C@@H]3[C@H]1C(=O)N(C3=O)c1ccc(C)cc1F)C(=O)c1ccccc1C2=O Show InChI InChI=1S/C28H20FNO5/c1-14-7-10-16(11-8-14)23-21-22(27(34)30(26(21)33)20-12-9-15(2)13-19(20)29)28(35-23)24(31)17-5-3-4-6-18(17)25(28)32/h3-13,21-23H,1-2H3/t21-,22-,23-/m1/s1 | PDB
Reactome pathway
UniProtKB/SwissProt
antibodypedia GoogleScholar
| PC cid PC sid UniChem
| PubMed
| n/a | n/a | n/a | n/a | 770 | n/a | n/a | n/a | n/a |
Chinese Academy of Sciences
Curated by ChEMBL
| Assay Description Agonist activity at recombinant human AC2 expressed in HEK293 cells assessed as increase in cAMP level measured after 30 mins by LANCE Ultra cAMP Det... |
Eur J Med Chem 191: (2020)
|
More data for this Ligand-Target Pair | |
Adenylate cyclase type 2
(Homo sapiens (Human)) | BDBM50551406
 (CHEMBL4740707)Show SMILES Cc1ccc(cc1)[C@H]1OC2([C@@H]3[C@H]1C(=O)N(C3=O)c1ccc(C)c(C)c1)C(=O)c1ccccc1C2=O Show InChI InChI=1S/C29H23NO5/c1-15-8-11-18(12-9-15)24-22-23(28(34)30(27(22)33)19-13-10-16(2)17(3)14-19)29(35-24)25(31)20-6-4-5-7-21(20)26(29)32/h4-14,22-24H,1-3H3/t22-,23-,24-/m1/s1 | PDB
Reactome pathway
UniProtKB/SwissProt
antibodypedia GoogleScholar
| PC cid PC sid UniChem
| PubMed
| n/a | n/a | n/a | n/a | 210 | n/a | n/a | n/a | n/a |
Chinese Academy of Sciences
Curated by ChEMBL
| Assay Description Agonist activity at recombinant human AC2 expressed in HEK293 cells assessed as increase in cAMP level measured after 30 mins by LANCE Ultra cAMP Det... |
Eur J Med Chem 191: (2020)
|
More data for this Ligand-Target Pair | |
Adenylate cyclase type 2
(Homo sapiens (Human)) | BDBM50551444
 (CHEMBL4763908)Show SMILES COc1cccc(c1)N1C(=O)[C@H]2[C@H](OC3([C@H]2C1=O)C(=O)c1ccccc1C3=O)c1ccc(C)cc1 Show InChI InChI=1S/C28H21NO6/c1-15-10-12-16(13-11-15)23-21-22(27(33)29(26(21)32)17-6-5-7-18(14-17)34-2)28(35-23)24(30)19-8-3-4-9-20(19)25(28)31/h3-14,21-23H,1-2H3/t21-,22-,23-/m1/s1 | PDB
Reactome pathway
UniProtKB/SwissProt
antibodypedia GoogleScholar
| PC cid PC sid UniChem
| PubMed
| n/a | n/a | n/a | n/a | 960 | n/a | n/a | n/a | n/a |
Chinese Academy of Sciences
Curated by ChEMBL
| Assay Description Agonist activity at recombinant human AC2 expressed in HEK293 cells assessed as increase in cAMP level measured after 30 mins by LANCE Ultra cAMP Det... |
Eur J Med Chem 191: (2020)
|
More data for this Ligand-Target Pair | |
Adenylate cyclase
(Homo sapiens (Human)) | BDBM50004822
 ((R)-1-phenyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine...)Show InChI InChI=1S/C16H17NO2/c18-15-8-12-6-7-17-10-14(13(12)9-16(15)19)11-4-2-1-3-5-11/h1-5,8-9,14,17-19H,6-7,10H2/t14-/m1/s1 | PDB
Reactome pathway
UniProtKB/SwissProt UniProtKB/TrEMBL
antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia antibodypedia GoogleScholar
| Purchase
CHEMBL MCE PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 71 | n/a | n/a | n/a | n/a |
University of Lund
Curated by ChEMBL
| Assay Description Compound was tested for the adenylate cyclase stimulation |
J Med Chem 35: 502-7 (1992)
Article DOI: 10.1021/jm00081a010 BindingDB Entry DOI: 10.7270/Q2TH8N95 |
More data for this Ligand-Target Pair | |
Adenylate cyclase type 2
(Homo sapiens (Human)) | BDBM50551405
 (CHEMBL4784488)Show SMILES Cc1ccc(cc1)[C@H]1OC2([C@@H]3[C@H]1C(=O)N(C3=O)c1ccc(F)c(Cl)c1)C(=O)c1ccccc1C2=O Show InChI InChI=1S/C27H17ClFNO5/c1-13-6-8-14(9-7-13)22-20-21(26(34)30(25(20)33)15-10-11-19(29)18(28)12-15)27(35-22)23(31)16-4-2-3-5-17(16)24(27)32/h2-12,20-22H,1H3/t20-,21-,22-/m1/s1 | PDB
Reactome pathway
UniProtKB/SwissProt
antibodypedia GoogleScholar
| PC cid PC sid UniChem
| PubMed
| n/a | n/a | n/a | n/a | 520 | n/a | n/a | n/a | n/a |
Chinese Academy of Sciences
Curated by ChEMBL
| Assay Description Agonist activity at recombinant human AC2 expressed in HEK293 cells assessed as increase in cAMP level measured after 30 mins by LANCE Ultra cAMP Det... |
Eur J Med Chem 191: (2020)
|
More data for this Ligand-Target Pair | |